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Human bocavirus (HBoV) is a newly described human pathogen 
that has been frequently associated with upper and lower 
respiratory tract infections. The reported prevalance of the 
virus has been ranging from 2% to 19% (1,2). HBoV infections 
are frequently detected in <2-year-old children often with 
other respiratory viruses (3,4). The clinical manifestatons of 
HBoV respiratory tract infection have ranged from mild upper 
respiratory disease (3,4) to severe life-threatening pneumonia 
(2,5). The direct impact of HBoV infection of the respiaratory 
tract is often difficult to assess because of its frequent detection 
in asymptomatic children and coinfection with other respiratory 
viruses in symptomatic children (4,6). A causal link between 
HBoV and respiratory disease has been reported but the exact 
clinical characteristics await determination. In children HBoV 
may cause more severe clininical conditions such as encephalitis 
and life-threatening complications (7,8). Although previously 
bocavirus associated hepatitis in an immuncompromised patient 
was mentioned in a single case report (9) here, we confirmed 
HBoV infection in an immunocompetent 2-years-5-months-old 
girl with hypoxia, cough, fever demonstrating respiratory tract 
infection along with hepatitis. To the best of our knowledge 
this is the first reported case of possible bocavirus associated 
hepatitis in an immunocompetent child.
CASE PRESENTATION
A previously healthy 2-year-5-month-old girl was admitted to 
our hospital with complaints of fever, vomiting, abdominal pain 
and runny nose for the previous 5 days. No diarrhoea or any rash 
was present. Her past medical history was unremarkable. She 
had never been hospitalized previously. There was no history of 
any medication usage or toxin exposure and no travel history. 
Because of respiratory distress, manifested by nasal flaring, 
intercostal, subcostal and suprasternal retractions, a respiratory 
1Department of Pediatrics, Çukurova University School of Medicine, Adana, Turkey
2Department of Pediatrics, Division of Pediatric Gastroenterology, Başkent University School of Medicine, Adana, Turkey
Background: So far, many studies have shown that 
Human Bocavirus ( HBoV) is the main pathogen of 
the respiratory tract. Until now, there is no study that 
proves the association between HBoV and hepatitis. 
HBoV viremia/DNAemia has been associated closely 
with acute primary infection and moderate-to-severe 
illness but, more detailed clinical data about HBoV 
dissemination are still unavailable.
Case Report: Here we report a 2-years-5-months-old girl 
suffering from respiratory distress and heptitis followed 
in our intensive care unit.  HBoV was detected in our 
patients nose and throat swabs concurrent with whole 
blood sample  by positive polymerase chain reactions. 
After a through investigation no causative agent other 
than HBoV viremia was found.
Conclusion: Human Bocavirus viremia with high viral 
loads may be associated with hepatitis. 
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rate of 80 breaths per minute and cyanosis, heated humidified 
high-flow nasal cannula (HFNC) therapy was used in our 
intensive care unit to reduce the work of breathing. At the time 
of admission, her laboratory findings were as follows; white 
blood cell count 13x109/L, absolute neutrophil count 2500, 
haemoglobin 9.2 g/dL platelet counts 330x109/L, C-reactive 
protein level 47.8 mg/dL, alanine aminotransferase level 4113 
U/L, aspartate aminotransferase level 7055 U/L, total biluribin 
0.8 mg/dL, direct biluribin 0.6 mg/dL, activated partial 
thromboplastin time 31.6 seconds, prothrombin time 24.9 
seconds, international correction rate 2.38, albumin 25 g/L. 
The gamma-glutamyl transpeptidase and alkaline phosphatase 
were normal. Laboratory and clinical findings were consistent 
with hepatitis and bronchiolitis. Serological testing were as 
follows: mycoplasma IgM(-), IgG(-), HBsAg(-), AntiHbs(+), 
HAV IgM(-), HAV IgG(-), AntiHCV(-), AntiHIV(-), EBV 
IgM(-), EBV IgG(-), CMV IgM(-), CMV IgG(-), human 
herpes virus 6 (-) herpes IgM(-) herpes IgG(-). Varicella 
IgM(-), IgG(+). Lyme IgM(-), IgG(-) Rose Bengal and Wright 
tests for salmonella and brucellosis serology was negative. 
Blood culture was negative for bacterial infections. Stool and 
blood specimens were negative for enteroviral infections. 
No spesific causative agent of hepatitis was found after a 
through investigation. At the time of admission, a diagnostic 
PCR analysis of a nasopharyngeal aspirate (NPA) swab was 
performed (LightCyler 2.0; Roche, Germany). HBoV, human 
coronavirus group 1 and group 2, human metapneumovirus, 
influenza virus types A and B, and respiratory syncytial virus, 
adenovirus, parainfluenza virus 1-4 and Rhinovirus were 
searched for the diagnostic panel. NPA was positive for only 
HBoV, PCR analysis was negative for all other viruses. HBoV 
viral load was detected 8x106 copies per ml serum in blood 
samples concurrent with the NPA. The patient’s respiratory 
status was improved over three days to normal. The hepatitis 
did not become severe and with supportive medical treatment 
the patient was discharged four days after admission. The 
written informed consent for participating in this report was 
obtained from the parents of the child. 
DISCUSSION
HBoV has been determined in patients with respiratory 
infections but its association with hepatitis has been shown only 
by one report. A case report from Finland in 2008 described 
an immunodeficient six-month-old boy without respiratory 
symptoms with hepatitis (9). HBoV DNA was identified from 
the NPA and blood of their patient by PCR, and diagnosis of 
acute primary HBoV infection was confirmed by specific IgM 
positivity in serum, and a fourfold rise of IgG antibody levels 
in paired sera. Here we described an immunocompetent child 
with HBoV infection with clinical hepatitis and respiratory 
symptoms but without other concomitant viruses. The sole 
detected pathogen was the HboV, both in the NPA and blood of 
our patient. Respiratory infections due to HBoV are systemic 
and can be diagnosed serologically, but in our case serological 
diagnosis of HBoV was not done because these tests were 
not available at our institution. Although diagnostic serology 
is helpful for disclosing HBoV infection with disease, some 
studies suggest that the detection of a high viral load of HBoV 
genomic DNA in blood may be useful in establishing the 
diagnosis of HBoV infection with disease (10), and one study 
also suggested that if HBOV viremia occurs it can disseminate 
to other parts of the body (1). 
When a sole viral finding in the respiratory tract is made, HBoV 
infection usually occurs with viremia and high viral loads and 
is often accompanied by the evidence of specific IgM and IgG 
antibodies (1,10). 
In light of these findings we can conclude that the high HBoV 
viral load in the blood sample of our patient can be considered 
as evidence of acute HBoV disease and hepatitis may be the 
clinical result of the dissemination of HBoV viremia.
There is limited data about the link between HBoV and hepatitis. 
To date, the pathogenesis of HBoV infection has not been fully 
elucidated. HBoV can be cultured only in differentiated human 
airway epithelial cells and no animal model is available. We 
detected HBoV as a sole pathogen both in blood and NPA 
samples. There are confusing data about the disease severity 
of single HBoV infections compared with HBoV co-infections 
in respiratory syndromes. Some authors suggest a more severe 
clinical picture with a high blood load with mono-infection 
(1,10). 
Although the definitive diagnosis of HBoV hepatitis requires 
the demonstration of the virus in a liver biopsy specimen, in our 
case a liver biopsy was not done. The diagnosis was made based 
upon an HBoV viremia and a compatible clinical picture with 
the exclusion of other causes. The findings strongly suggest the 
HBoV as a causative agent. The true HBoV pathogenesis is not 
yet fully understood. Also, the link between HBoV and hepatitits 
requires supporting evidence. Tropism of HBoV to the hepatic 
tissue can be studied further. To the best of our knowledge, this 
is the first report that demonstrates HBov viral load in both 
nasal and blood samples from an immunocompetent child with 
hepatitis and respiratory infection but without mixed infections 
with other viruses, thus supporting the hypothesis that HBoV 
may cause hepatitis.
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